\-\ Texto\\:\\ \ \(0\)\
\-\ thin\\ hirsuite\\ hispanic\\ female\\ in\\ no\\ apparent\\ distress\\.\\ \\ pelvic\\ exam\\ demonstrates\\ vulvar\\ irregularities\\ and\\ questionable\\ clitoralmegaly\\.\\ \\ bi\\-manual\\ exam\\ is\\ normal\\.\ \(0\)\
\-\ labs\\ show\\ increased\\ levels\\ of\\ 17\\ hydroxy\\ progesterone\\ in\\ blood\\ and\\ elevated\\ 17\\-ketosteroids\\ in\\ urine\\.\ \(0\)\
\-\ patient\\ was\\ put\\ on\\ hormone\\ therapy\\ and\\ instructed\\ to\\ follow\\ up\\ with\\ endocrinology\\ after\\ genetic\\ counseling\\.\ \(0\)\
\-\ contrast\\ enhanced\\ ct\\ image\\ through\\ the\\ adrenals\\ shows\\ marked\\ symmetric\\ enlargement\\ of\\ the\\ adrenals\\ and\\ no\\ other\\ significant\\ abnormality\\.\ \(0\)\
\-\ congenital\\ adrenal\\ hyperplasia\ \(4\)\
\-\ congenital\\ adrenal\\ hyperplasia\ \(4\)\
\-\ cushing\\'s\\ syndrome\ \(0\)\
\-\ conn\\'s\\ syndrome\ \(0\)\
\-\ primary\\ bilateral\\ adrenocortial\\ neoplasms\ \(0\)\
\-\ diffuse\\ lymphoma\\ or\\ metastatic\\ disease\ \(0\)\
\-\ patient\\ presents\\ to\\ her\\ primary\\ care\\ provider\\ with\\ non\\-specific\\ abdominal\\ and\\ pelvic\\ complaints\\ for\\ the\\ last\\ several\\ months\\.\\ \\ no\\ fever\\.\ \(0\)\
\-\ this\\ case\\ represents\\ an\\ uncommon\\ diagnosis\\ in\\ an\\ adult\\ with\\ bilateral\\ adrenal\\ hyperplasia\\.\\ \\ in\\ most\\ circumstances\\,\\ cushings\\ would\\ be\\ far\\ more\\ likely\\.\\ \\ in\\ this\\ case\\,\\ the\\ imaging\\,\\ physical\\ exam\\ and\\ labs\\ corroborate\\ perfectly\\ with\\ the\\ diagnosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adrenals\\:\\ 0\\.08951652809357015\ \(0\)\
\-\ adrenal\\:\\ 0\\.08062513144536072\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.07845369387537404\ \(0\)\
\-\ hirsuite\\:\\ 0\\.05475477281966769\ \(0\)\
\-\ clitoralmegaly\\:\\ 0\\.05475477281966769\ \(0\)\
\-\ bi\\-manual\\:\\ 0\\.05475477281966769\ \(0\)\
\-\ 17\\-ketosteroids\\:\\ 0\\.05475477281966769\ \(0\)\
\-\ adrenocortial\\:\\ 0\\.05475477281966769\ \(0\)\
\-\ vulvar\\:\\ 0\\.050449510828612126\ \(0\)\
\-\ hydroxy\\:\\ 0\\.050449510828612126\ \(0\)\
\-\ conn\\:\\ 0\\.050449510828612126\ \(0\)\
\-\ corroborate\\:\\ 0\\.050449510828612126\ \(0\)\
\-\ perfectly\\:\\ 0\\.04793109400806452\ \(0\)\
\-\ cushings\\:\\ 0\\.046144248837556565\ \(0\)\
\-\ pelvic\\:\\ 0\\.04356833200702227\ \(0\)\
\-\ progesterone\\:\\ 0\\.041838986846501\ \(0\)\
\-\ circumstances\\:\\ 0\\.041107415196461355\ \(0\)\
\-\ cushing\\:\\ 0\\.03986101336129272\ \(0\)\
\-\ instructed\\:\\ 0\\.03882341035096249\ \(0\)\
\-\ congenital\\:\\ 0\\.03882185055456444\ \(0\)\
\-\ endocrinology\\:\\ 0\\.03793458523518191\ \(0\)\
\-\ counseling\\:\\ 0\\.03753372485544544\ \(0\)\
\-\ labs\\:\\ 0\\.03691893176316942\ \(0\)\
\-\ irregularities\\:\\ 0\\.0368021532054058\ \(0\)\
\-\ put\\:\\ 0\\.03646633195527986\ \(0\)\
\-\ exam\\:\\ 0\\.0349795144089976\ \(0\)\
\-\ hispanic\\:\\ 0\\.03362932324412635\ \(0\)\
\-\ provider\\:\\ 0\\.03267186560544773\ \(0\)\
\-\ primary\\:\\ 0\\.03144576724094032\ \(0\)\
\-\ non\\-specific\\:\\ 0\\.030710046043842282\ \(0\)\
\-\ syndrome\\:\\ 0\\.030359087909747097\ \(0\)\
\-\ hormone\\:\\ 0\\.030094574598847058\ \(0\)\
\-\ questionable\\:\\ 0\\.02997847439380263\ \(0\)\
\-\ far\\:\\ 0\\.02997847439380263\ \(0\)\
\-\ genetic\\:\\ 0\\.02902101675512401\ \(0\)\
\-\ neoplasms\\:\\ 0\\.027016213076471517\ \(0\)\
\-\ adult\\:\\ 0\\.02660198093672821\ \(0\)\
\-\ uncommon\\:\\ 0\\.02596763624681281\ \(0\)\
\-\ 17\\:\\ 0\\.025848186793844565\ \(0\)\
\-\ bilateral\\:\\ 0\\.025761710923160795\ \(0\)\
\-\ urine\\:\\ 0\\.025615966097747543\ \(0\)\
\-\ represents\\:\\ 0\\.02550303243884574\ \(0\)\
\-\ diagnosis\\:\\ 0\\.024375395413421364\ \(0\)\
\-\ symmetric\\:\\ 0\\.02424138843621395\ \(0\)\
\-\ apparent\\:\\ 0\\.023469352928899807\ \(0\)\
\-\ \\'s\\:\\ 0\\.02340430581822416\ \(0\)\
\-\ case\\:\\ 0\\.023223657551146217\ \(0\)\
\-\ complaints\\:\\ 0\\.02304082577680694\ \(0\)\
\-\ enhanced\\:\\ 0\\.022710951085415956\ \(0\)\
\-\ last\\:\\ 0\\.022675356832565118\ \(0\)\
\-\ distress\\:\\ 0\\.022363867492903804\ \(0\)\
\-\ levels\\:\\ 0\\.021908393747030824\ \(0\)\
\-\ thin\\:\\ 0\\.02181499078203368\ \(0\)\
\-\ enlargement\\:\\ 0\\.021059431096180716\ \(0\)\
\-\ marked\\:\\ 0\\.02071353727095967\ \(0\)\
\-\ abnormality\\:\\ 0\\.019581105241183554\ \(0\)\
\-\ care\\:\\ 0\\.019143957435209642\ \(0\)\
\-\ would\\:\\ 0\\.018887993033677573\ \(0\)\
\-\ elevated\\:\\ 0\\.018008176157509707\ \(0\)\
\-\ fever\\:\\ 0\\.0179581529599501\ \(0\)\
\-\ several\\:\\ 0\\.017062688420635946\ \(0\)\
\-\ follow\\:\\ 0\\.01686459299345611\ \(0\)\
\-\ image\\:\\ 0\\.016578814697500624\ \(0\)\
\-\ show\\:\\ 0\\.016292894003053577\ \(0\)\
\-\ diffuse\\:\\ 0\\.016068369070654127\ \(0\)\
\-\ no\\:\\ 0\\.01603312082056774\ \(0\)\
\-\ her\\:\\ 0\\.015959078624130034\ \(0\)\
\-\ in\\:\\ 0\\.015704244601500186\ \(0\)\
\-\ lymphoma\\:\\ 0\\.015168935617325997\ \(0\)\
\-\ through\\:\\ 0\\.015074267195160673\ \(0\)\
\-\ likely\\:\\ 0\\.014970745130035133\ \(0\)\
\-\ an\\:\\ 0\\.014679066637077388\ \(0\)\
\-\ shows\\:\\ 0\\.01459238322812968\ \(0\)\
\-\ months\\:\\ 0\\.014496529780683647\ \(0\)\
\-\ blood\\:\\ 0\\.014487025295088815\ \(0\)\
\-\ up\\:\\ 0\\.01427234255313182\ \(0\)\
\-\ significant\\:\\ 0\\.01427234255313182\ \(0\)\
\-\ therapy\\:\\ 0\\.014190315504600079\ \(0\)\
\-\ metastatic\\:\\ 0\\.013360927972770746\ \(0\)\
\-\ more\\:\\ 0\\.01327438701436128\ \(0\)\
\-\ abdominal\\:\\ 0\\.013266579118770902\ \(0\)\
\-\ physical\\:\\ 0\\.013021771860753033\ \(0\)\
\-\ increased\\:\\ 0\\.012984377526705936\ \(0\)\
\-\ imaging\\:\\ 0\\.012435241145686973\ \(0\)\
\-\ most\\:\\ 0\\.012253634420671278\ \(0\)\
\-\ other\\:\\ 0\\.01223377980560527\ \(0\)\
\-\ this\\:\\ 0\\.011939592711976808\ \(0\)\
\-\ contrast\\:\\ 0\\.011880594327999412\ \(0\)\
\-\ demonstrates\\:\\ 0\\.011593920507162646\ \(0\)\
\-\ after\\:\\ 0\\.010981373929249704\ \(0\)\
\-\ female\\:\\ 0\\.010911554481042444\ \(0\)\
\-\ presents\\:\\ 0\\.010842511152223141\ \(0\)\
\-\ patient\\:\\ 0\\.010640893551756372\ \(0\)\
\-\ disease\\:\\ 0\\.008675388454755927\ \(0\)\
\-\ normal\\:\\ 0\\.008320574252168329\ \(0\)\
\-\ be\\:\\ 0\\.008184824368595833\ \(0\)\
\-\ ct\\:\\ 0\\.007424246294360515\ \(0\)\
\-\ and\\:\\ 0\\.006708410151511247\ \(0\)\
\-\ or\\:\\ 0\\.006220638192321164\ \(0\)\
\-\ was\\:\\ 0\\.006138369703190601\ \(0\)\
\-\ to\\:\\ 0\\.005305193893701692\ \(0\)\
\-\ \\,\\:\\ 0\\.0050442869351047335\ \(0\)\
\-\ for\\:\\ 0\\.0045286220412591\ \(0\)\
\-\ on\\:\\ 0\\.004496217468108249\ \(0\)\
\-\ the\\:\\ 0\\.004293456046696453\ \(0\)\
\-\ is\\:\\ 0\\.003492489306737426\ \(0\)\
\-\ with\\:\\ 0\\.0029069360519227263\ \(0\)\
\-\ \\.\\:\\ 0\\.0024254341432969504\ \(0\)\
\-\ of\\:\\ 0\\.0014472521838259432\ \(0\)\
